Daniela Buchmayr
Daniela Buchmayr brings over 15 years of experience to the biopharmaceutical sector. She earned an engineering degree in biotechnology and genetic engineering, further enhanced by an MBA in Innovation and Entrepreneurship from the Economic University of Vienna. Throughout her career, Daniela has held multiple management roles at international companies, leading the design and implementation of innovative market and business development strategies. Her leadership has been instrumental in driving transformational and cross-functional projects.
As the CEO and co-founder of Sarcura, a Vienna-based deep tech start-up, Daniela is leading a transformative shift in cell therapy manufacturing toward miniaturized, autonomous systems. By leveraging advanced semiconductor technologies within microfluidic cartridges, Sarcura aims to significantly enhance production process efficiency and dramatically reduce costs. This advancement is poised to broaden access to life-saving therapies, representing a pivotal step forward in the field."
Authored articles
“With the help of imec, we want to shrink a complete cell manufacturing plant onto chips”
Deep-tech venture Sarcura is collaborating with imec to develop, prototype and produce a cell sorter chip with integrated photonics to make cell therapy available for all patients who need it (instead of the < 5% that have access today).
Read more